ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegaly-Reference-Cited by-同舟云学术

ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegaly

Published:2019-05 Issue:5 Volume:66 Page:320-329
ISSN:2530-0164
Container-title:Endocrinología, Diabetes y Nutrición
language:en
Short-container-title:Endocrinología, Diabetes y Nutrición

Author:

Álvarez-Escolá Cristina,Venegas-Moreno Eva María,García-Arnés Juan Antonio,Blanco-Carrera Concepción,Marazuela-Azpiroz Mónica,Gálvez-Moreno María Ángeles,Menéndez-Torre Edelmiro,Aller-Pardo Javier,Salinas-Vert Isabel,Resmini Eugenia,Torres-Vela Elena María,Gonzalo-Redondo María Ángeles,Vílchez-Joya Ricardo,de Miguel-Novoa María Paz,Halperín-Rabinovich Irene,Páramo-Fernández Concepción,de la Cruz-Sugranyes Guillermo,Houchard Aude,Picó-Alfonso Antonio Miguel

Funder

Ipsen Pharma S.A., Spain

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. Acromegaly;Reddy;BMJ,2010

2. Acromegaly: an endocrine society clinical practice guideline;Katznelson;J Clin Endocrinol Metab,2014

3. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly;Holdaway;Eur J Endocrinol,2008

4. Expert consensus document: a consensus on the medical treatment of acromegaly;Giustina;Nat Rev Endocrinol,2014

5. Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension;Melmed;Pituitary,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The socioeconomic burden of acromegaly;European Journal of Endocrinology;2023-08

2. A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly;Pituitary;2022-11-29

3. Targeted treatment with somatostatin analogues: widening horizons of clinical practice;Almanac of Clinical Medicine;2022-10-26

4. Do We Need a Specific Guideline for Assessment and Improvement of Acromegaly Patients Adherence?;Frontiers in Public Health;2021-07-14

5. Benefits of a nurse-led home injection service for acromegaly patients treated with somatuline autogel;Endocrine;2020-10-24